Inflammation & Allergy - Drug Targets (Discontinued)
Title:Meet Our Editor:
Volume: 14 Issue: 1
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
Zaenker S. Kurt, Meet Our Editor:, Inflammation & Allergy - Drug Targets (Discontinued) 2015; 14 (1) . https://dx.doi.org/10.2174/187152811401151211113118
DOI https://dx.doi.org/10.2174/187152811401151211113118 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Journals
Related Books
21
Related Articles
-
Oesophagogastric Disconnection: Who, How and When? A Review Article
Current Pediatric Reviews Potential for Discovery of Neuroprotective Factors in Serum and Tissue from Hibernating Species
Mini-Reviews in Medicinal Chemistry Role of Interferons in Chronic Hepatitis C Infection
Current Drug Targets Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design MicroRNAs and Chronic Inflammation Contribution to Gastrointestinal Integrity
Current Medicinal Chemistry Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs Parasites in Rheumatoid Arthritis: Imminent Threat or Protective Effect?
Current Rheumatology Reviews Microglia and Inflammation in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients
Current Vascular Pharmacology Exploring Nitrostyrene as a Scaffold for a New Class a of Monoamine Oxidase Inhibitors
Letters in Drug Design & Discovery In Utero Exposure to Phthalates and Fetal Development
Current Medicinal Chemistry Editorial: Stress and Gastrointestinal Tract: Physiology, Pathophysiology, Pathology and Pharmacology
Current Pharmaceutical Design Monoclonal Antibody “Gold Rush”
Current Medicinal Chemistry Presenilin and γ -Secretase Activity: A Viable Therapeutic Target for Alzheimers Disease?
Current Signal Transduction Therapy A Short Course on Virology / Vectorology / Gene Therapy
Current Gene Therapy Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review
Current Pharmaceutical Design Treating Cancer in Older and Oldest Old Patients
Current Pharmaceutical Design Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action
CNS & Neurological Disorders - Drug Targets Biodegradable Polymer Hydrogels Based in Sorbitol and Citric Acid for Controlled Release of Bioactive Substances from Plants (Polyphenols)
Current Chemical Biology Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells
Current Cancer Therapy Reviews